SHSeyedeh Sedigheh Hamzavi

Seyedeh Sedigheh Hamzavi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyedeh Sedigheh Hamzavi has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Marzieh Jamalidoust

    Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    3 shared publications
  • Rosemina Bahrololoom

    Professor Alborzi Clinical Microbiology Research Center Shiraz University of Medical Sciences Shiraz Iran

    3 shared publications
  • Aida Askarisarvestani

    Division of Allergy and Clinical Immunology, Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    2 shared publications
  • Ali Amanati

    Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    2 shared publications
  • Alireza Dehghan

    Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    2 shared publications
  • Anahita Sanaei Dashti

    Professor Alborzi Clinical Microbiology Research Center Shiraz University of Medical Sciences Shiraz Iran

    2 shared publications

Latest Publications

  • Open Access

    Diminished Hepatitis B Antibody Response in Pediatrics With Type 1 Diabetes; the Need for Revaccination Protocol: A Case‐Control Study

    by Erfanehsadat Shahim, Rosemina Bahrololoom, Maryam Ataollahi, Marzieh Jamalidoust, Amirhossein Hasani, Homa Ilkhanipoor, Anahita Sanaei Dashti, Seyedeh Sedigheh Hamzavi

    Background and Aims: Hepatitis B virus (HBV) infection is a significant chronic infection in pediatric patients. Vaccination induces production of anti‐Hepatitis B surface antibodies, which serve as markers of protective immunity. Given the long‐term risks of cirrhosis and hepatocellular carcinoma during adulthood, this study aimed to assess and compare seroprotection between children with type 1 diabetes mellitus (T1DM) and nondiabetic participants. Methods: In this case‐control study, 127 children with T1DM and 124 controls, all in a healthy immune state and fully vaccinated against HBV, were recruited from Shiraz University pediatric endocrinology clinics. Exclusion criteria included immunosuppression, incomplete vaccination, or hepatitis history in the child/family. Ethical approval was obtained from Shiraz University of Medical Sciences. Comparisons of sex, age, antibody titers, and diabetes indices used appropriate inferential tests; odds of inadequate antibody titers were assessed by logistic regression. Results: Considering an antibody titer of 10 mIU/mL as adequate, the non‐protection rate was 54.3% (95% CI: 45.3%–63.2%) in diabetic individuals and 28.2% (95% CI:20.5%–37.0%) in non‐diabetics. In a multivariable model controlling for time from vaccination, time from vaccination (OR = 1.26, 95% CI: 1.06–1.49, p < 0.001), and diabetes status (OR = 2.34, 95% CI: 1.33–4.14, p = 0.002) contributed to inadequate antibody titers. Sex, glycemic control, and disease duration over 1 year had no significant effect. Conclusion: Children with type 1 Diabetes Mellitus exhibited lower anti‐HBs antibody titers compared to their nondiabetic counterparts, with no association found with sex or glycemic control. The timing of vaccination and diabetes status should be considered when evaluating immune responses to HBV vaccination in children.

  • Open Access

    Trends in Pediatric Respiratory Viral Infections in Southwest Iran Following the COVID-19 Pandemic (2022 - 2023 Cold Season)

    by Marzieh Jamalidoust, Marzieh Hosseini, Mandana Namayandeh, Seyedeh Sedigheh Hamzavi, Mohammad Rahim Kadivar

    Background: Respiratory viral infections changed substantially during the COVID-19 pandemic. Evaluating post-pandemic viral circulation is important to understand the resurgence and clinical patterns of common pediatric respiratory viruses. Objectives: This study aimed to determine trends in viral respiratory infections and their associated clinical symptoms during the cold season at the end of the COVID-19 pandemic in Iran. Methods: A total of 1,530 respiratory samples from hospitalized children diagnosed with acute respiratory infections were included. Demographic characteristics and clinical signs and symptoms were recorded. A multiplex real-time polymerase chain reaction assay was used to detect common respiratory viruses, including SARS-CoV-2, influenza, respiratory syncytial virus, and rhinovirus, in patient samples collected from October 2022 to April 2023. Results: Among 1,530 hospitalized children with respiratory symptoms, 36.3% had at least one viral detection. Influenza was the most frequently identified virus (11.3%), followed by respiratory syncytial virus (10.5%), SARS-CoV-2 (9.8%), and rhinovirus (4.7%). Most infections occurred in children younger than 2 years, with a peak incidence in January. Coinfections were infrequent and most commonly involved rhinovirus. Influenza and respiratory syncytial virus infection rates were significantly higher in children aged ≥ 3 years and < 3 years, respectively. However, COVID-19 and rhinovirus infection rates did not differ significantly among age groups. Clinical presentations varied across viral groups. Conclusions: Given changes in health guidelines and waning antibody levels, it is important to examine the behavior and frequency of respiratory viruses in the post-COVID-19 period. This study demonstrated the resurgence of influenza and respiratory syncytial virus following the pandemic.

  • Open Access

    Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis

    by Mehdi Forooghi, Seyedeh Sedigheh Hamzavi, Shayan Yousufzai, Bita Geramizadeh, Simin Sharifi, Sara Nasiri

    Gastrointestinal basidiobolomycosis is a rare fungal infection caused by Basidiobolus ranarum, increasingly recognized as an intestinal pathogen in childre


  • Open Access

    Identification of Viral Causes in Cerebrospinal Fluid of Patients Under Investigation for Central Nervous System Infections During the COVID-19 Epidemic: A Cross-Sectional Study

    by Nasrin Aliabadi, Nahid Heydari Marandi, Gholamreza Pouladfar, Seyedeh Sedigheh Hamzavi, Marzieh Hosseini, Rosemina Bahrololoom, Marzieh Jamalidoust, Mazyar Ziyaeyan

    Background: Although viral etiology of central nervous system (CNS) infections such as meningitis and encephalitis are investigated widely worldwide, it remains to be declared under the COVID-19 pandemic. Objectives: The focus of this study was to examine the etiology of viral CNS infections in patients hospitalized in a single referral hospital during the outbreak in Iran. Methods: We retrospectively collected the cerebrospinal fluid (CSF) samples and reviewed the medical records of patients hospitalized with suspected viral CNS infection in Shiraz, a large city in southern Iran, from April 2021 to May 2022. One hundred sixty-six CSF samples were tested primarily for detection of HSV-1 and -2 and retrospectively analyzed by primers polymerase chain reaction (PCR) targeted to coronavirus 2 (SARS-CoV-2), human herpesviruses1 to 6 (HHV-1 to 6), polyomaviruses JC, and enteroviruses (EV). Results: Of the total CSF samples analyzed by PCR, 22 (13.3%) were positive for only one viral pathogen, and just one (0.6%) sample was detected with multiple viruses (HSV-1 and CMV). The SARS-CoV-2 (6 cases) was the second most common viral etiology just after Herpes simplex virus-1 (HSV-1) 6.6% (11 cases). Other detected viruses were CMV for 1.8% (3 cases), VZV for 1.2% (2 cases), and JC for 0.6% (1 case) of the cases. Conclusions: This study highlights the prevalence of viral pathogens in CSF samples from patients with suspected meningitis at Namazi Teaching Hospital. Notably, HSV-1 was the most common virus detected, followed by SARS-CoV-2. These findings underscore the importance of viral testing in the diagnosis and management of meningitis.


  • Open Access

    Nonfamilial cherubism in a 6-month-old infant: a case report

    by Seyedeh Sedigheh Hamzavi, Alireza Askari, Rosemina Bahrololoom, Maral Mokhtari, Anahita Sanaei Dashti, Fatemeh Yarmahmoodi, Somaye Rashidi

    Background: Cherubism is known as a very rare autosomal dominant familial disorder of childhood caused by a mutation in the SH3BP2 gene on 4p16.3. It has not yet been observed at birth and is usually diagnosed in children aged 2–7. Here, we present a non-hereditary case of cherubism at a very early age. Case presentation: A 6-month-old girl presented with bilateral progressive jaw enlargement. On physical examination, bilateral asymmetrical jaw enlargement, predominantly on the left side, and some enlarged, non-tender, mobile submandibular lymph nodes were detected. No other abnormality was observed. Further investigations with radiology suggested cherubism and Burkitt’s lymphoma as differential diagnoses. Later on, histopathologic evaluations were suggestive of cherubism. No surgical interventions were indicated, and the child is on regular follow-ups. Conclusion: Non-hereditary Cherubism, despite scarcity, can present in children below two years of age, even as early as the beginning of primary dentition. Accurate and swift diagnosis is essential to avert physical and psychological complications. Our case report shows the importance of keeping cherubism in mind as a differential diagnosis of bone disease, even in children under a year old, and the value of interdisciplinary collaboration in dealing with rare genetic disorders.


  • Case Report: Gastrointestinal Basidiobolomycosis in a Young Girl with Cystic Fibrosis and Celiac Disease

    by Ali Tadayon, Omid Reza Azh, Mostafa Poor Khosravani, Seyedeh Sedigheh Hamzavi, Fatemeh Yarmahmoodi, Babak Shirazi Yeganeh, Mehdi Ghasemian

    : Basidiobolomycosis is an uncommon fungal infection that has been reported in the literature mainly as a cause of infection in the skin and subcutaneous tissue. Intraabdominal infections have been reported in tropical and subtropical areas in the Middle East, such as Iran and Saudi Arabia, and in the United States. Our patient was a 6-year-old girl with cystic fibrosis and celiac disease who was referred to our department with a history of chronic abdominal pain. In the imaging studies of the abdomen and pelvis, a large retroperitoneal mass was reported in the right upper part of the abdomen with involvement of the duodenum and the mesentery of the small and large intestines, as well as the superior mesenteric vessels, and was diagnosed as basidiobolomycosis through biopsy. Because of the large unresectable mass, the patient was first treated with antifungal drugs for 2 months and then surgical resection was performed. The main point in the management of these patients is a combination of antifungal therapy and surgical resection. In some patients, complex surgeries such as the Whipple procedure may be performed to appropriately manage intraabdominal infections.


  • Open Access

    Comparing clinical presentation, viremia, and immunological factors at various severity presentations in hospitalized children affected by COVID‐19: A cross‐sectional study

    by Marzieh Jamalidoust, Seyedeh Sedigheh Hamzavi, Eslam Shorafa, Mandana Namayandeh, Laiba Batool, Seyedeh Narges Abootalebi

    Background and Aims: Although SARS‐CoV‐2 infection usually leads to mild COVID‐19 in children, sometimes it causes serious complications, especially in those with underlying diseases. Several factors have been identified in determining disease severity in adults, and limited studies have been conducted in children. The prognostic implications of SARS‐CoV‐2 RNaemia as an important factor in determining disease severity in children are not well understood.Methods: In this study, we aimed to prospectively assess the relationship between disease severity and immunological factors and viremia in 47 COVID‐19 hospitalized children. In this research, 76.5% of children experienced mild and moderate COVID‐19, while 23.5% experienced severe and critical forms of the disease.Results: The presence of underlying diseases in different groups of pediatric patients differed significantly from each other. On the other hand, clinical symptoms such as vomiting and chest pain as well as laboratory parameters including erythrocyte sedimentation rate were significantly different in different groups of patients. Viremia was seen in only two children, and this had no significant relationship with the severity of COVID‐19.Conclusion: In conclusion, our data confirmed that COVID‐19 severity differed in SARS‐CoV‐2 infected children. Some clinical presentation and lab data parameters were different in various presentation of patients. Viremia was not associated with severity in our study.


  • Open Access

    Terminal ileitis and cytotoxic lesion of corpus callosum as the presenting features of Multisystem inflammatory syndrome in children (MIS-C): a case report

    by Marzieh Davoodi, Gholamreza Pouladfar, Mohammad Rahim Kadivar, Alireza Dehghan, Aida Askarisarvestani, Seyedeh Sedigheh Hamzavi

    Background: Multisystem inflammatory syndrome in children (MIS-C) is a post-viral inflammatory vasculopathy characterized by persistent fever, multiorgan dysfunction, significant laboratory markers of inflammation, lack of an alternative diagnosis, and prior SARS-CoV-2 infection or exposure in children and adolescents. The most common early symptoms include a prolonged fever, as well as dermatologic, mucocutaneous, and gastrointestinal symptoms such abdominal pain, vomiting, and diarrhea. Case presentation: We present a pediatric patient with multisystem inflammatory syndrome with the development of abdominal pain and seizure who was found to have a circumferential wall thickening of the terminal ileum and ileocecal junction in abdominal CT scan. The brain MRI of the patient showed cytotoxic lesions of the corpus callosum (CLOCC) which had hypersignal intensity with a few diffusion restrictions in the splenium of the corpus callosum. Conclusion: This case is being reported to raise awareness of MIS-C presenting characteristics. Given the rising number of MIS-C patients and a lack of understanding regarding early diagnostic clinical characteristics and therapy, further research into clinical presentations, treatment, and outcomes is urgently needed.


  • Open Access

    Prevalence of COVID-19 in Children with Gastrointestinal Manifestations: A Cross-sectional Study of 184 Cases in 2020 - 2021

    by Maryam Ataollahi, Seyedeh Sedigheh Hamzavi, Seyed Mohsen Dehghani, Mahmood Haghighat, Mohammad Hadi Imanieh, Naser Honar, Keramat Allah Jahanshahi, Behnaz Darban, Hoda Haghshenas, Mohammad Aref Bagherzadeh, et al.

    Background: The coronavirus disease 2019 (COVID-19) pandemic has affected human life for more than a year. COVID-19 is well known for its respiratory manifestations; however, other important symptoms help with its diagnosis. Although clinical presentations in adults have been understood, clinical data in pediatric COVID-19 cases are still lacking. Objectives: We investigated gastrointestinal (GI) manifestations of COVID-19 in pediatric cases. Methods: This study included 184 cases with GI manifestations referred to the pediatric emergency department of Namazi hospital from 20 March to 20 November 2020. Their clinical and laboratory data were extracted and analyzed with SPSS22. Results: Of 184 patients, 51 had positive SARS-CoV-2 PCR results. The most common symptom in SARS-CoV-2-positive patients was vomiting in 22 (43%) patients, followed by watery diarrhea in 12 (23.5%) and dysentery in 11 (21%). Significantly elevated CRP (P value = 0.002), ESR (P value < 0.001), and lymphocyte count (P value = 0.037) were found in PCR-positive patients. Conclusions: Our result demonstrates that COVID-19 could present with different GI symptoms. Also, the symptoms and lab data could help clinicians diagnose COVID-19, besides other differential diagnoses in pediatric patients with GI symptoms.


  • Open Access

    Clinical and Laboratory Characteristics of the Multisystem Inflammatory Syndrome in Children: A Case Series of 75 Patients

    by Shabnam Hajiani Ghotbabadi, Maryam Mollaie, Seyedeh Sedigheh Hamzavi, Anahita Sanaei Dashti

    Background: SARS-CoV-2 has been characterized since December 2019 as the etiology of severe pneumonia throughout the world. However, the majority of children and adolescents with the respective infection have mild COVID-19. In April 2020, a warning was issued by the National Health Service (NHS), based on which a multisystem inflammatory syndrome in children (MIS-C) could be associated with COVID-19, presenting with cardiovascular shock, fever, and hyperinflammation. The syndrome presents with fever and organ involvement but with no pathognomonic findings or diagnostic tests, while some of the manifestations are almost the same as those of Kawasaki disease. Objectives: Knowledge of clinical course, demographic data, treatment, and prognosis can contribute to the more efficient management of the patients and, consequently, a decrease in morbidity and mortality. Methods: Seventy-five patients < 18 years from September 22, 2020, to March 10, 2021, in Namazi hospital, Shiraz, Iran, with a diagnosis as per MIS-C defined criteria, were recruited. Results: Median age of the patients was 6.2 years, and 58.6% were male. Of the patients, 46% had positive SARS-CoV-2 RT-PCR, antibody, or both. Thirty percent of the total patients reported contact with proven COVID-19 cases. The abdominal free fluid in 17 patients, hepatitis in one patient, and stasis in both kidneys of one patient were detected. Upon echocardiography on the first day, 77%, 48%, 21%, and one patient were with tricuspid regurgitation, mitral regurgitation, abnormal LV function, and myocarditis, respectively; however, after 5 - 7 days, the repeated echocardiography revealed 44% of patients with tricuspid regurgitation, 30% with mitral regurgitation, and 6% with abnormal LV function. For the treatment, 18% of the patients received inotropes, 60% ASA, 32% IVIG, 84% glucocorticoids, and 25.3% received furosemide. All of the patients received antibiotics as well. Finally, 97% of the patients were discharged alive, while two cases died. Conclusions: The results of this study suggest the importance of cardiac consultation along with early hospital care during the course of MIS-C in order to prevent the associated short-term and long-term complications.